Opening of Research Centre on Biotech Business
You are cordially invited to the opening of a new centre at CBS, dedicated to research on
Biotech Business, on April 14th from 2 till 4 p.m.
With
Biotech Business, we wish to focus research on a number of the management and economic issues associated with biotechnology and with research-driven business in general. These areas are characterised not only by particular management challenges but also by their intensive interplay with universities, venture capital, the political system etc.
Biotechnology, as a wholly science-driven business, brings out with unusual clarity a set of issues that increasingly appear across a broader spectrum of industries, and which consequently must be reflected in research at CBS. In addition, the biotech field carries special significance for the Øresund region and thus for CBS?s interaction with neighbouring institutes and companies.
For these reasons, we now give added attention to this field. The
Biotech Business centre has just been supported with a significant, joint grant from the Research Councils, the biotech industry and CBS. The centre gathers projects, which are carried out at different CBS departments, and whose subjects span a broad range of issues, as evident from the enclosed, short summaries of current projects. Additional projects will be added to the centre in the future and will be presented in more detail on the homepage, which will be launched at the same time as the centre:
www.cbs.dk/biotech
Finn Junge-Jensen, President of CBS:
CBS and Biotech Business
· Ole Stenvinkel Nilsson, Dean of Faculty of Economics, CBS:
Innovations in research and teaching
· Børge Diderichsen, Vice-president of Corporate Research Affairs:
Science and Business in Biotechnology
in the Øresund Region
· Florian Schönharting, Partner Nordic Biotech:
Developing Biotech Business - The Venture Capital Perspective.
· Maureen McKelvey, Professor of Economics of Innovation, Chalmers University:
The Economic Dynamics of Modern Biotechnologies
· Finn Valentin, Professor, Director of
Biotech Business: The Agenda for
Biotech Business
After the opening programme, refreshments will be served.
Registrations for participation in the opening are due no later than March 31st:
Cordially,
Finn Valentin
Professor, Director of Biotech Business